GlassScriptPhysician profile
Gaurav K Shah
NPI 1972502383
$619,571.77
in general payments reported to CMS, 2019-2025
24 companies · $38K in 2025
The $38K reported for 2025 was more than what 98% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137K · 2020: $62K · 2021: $76K · 2022: $103K · 2023: $102K · 2024: $102K · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $158K · Consulting Fee: $39K · Travel and Lodging: $33K · Honoraria: $6,050 · Food and Beverage: $4,898 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $158,154.41 |
| Consulting Fee | $39,442.50 |
| Travel and Lodging | $32,823.34 |
| Honoraria | $6,050.00 |
| Food and Beverage | $4,897.63 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,443.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $287,563.70 | 2019-2025 | Eylea Hd, Eylea |
| Dutch Ophthalmic, USA | $74,960.22 | 2019-2024 | Tissueblue, Eva, Combined Machine |
| Allergan, INC. | $45,208.73 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $44,107.92 | 2019-2020 | |
| Biogen, INC. | $30,574.01 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $25,581.77 | 2019-2021 | |
| Dutch Ophthalmic Research Center (International) B.V. | $25,340.69 | 2019-2023 | Tissueblue, Eva, Combined Machine |
| Carl Zeiss Meditec USA, INC. | $18,759.51 | 2023-2025 | Cirrus Hd-Oct, Clarus, Iolmaster 700 |
| Abbvie INC. | $18,635.42 | 2022-2025 | Ozurdex |
| Carl Zeiss Meditec, INC. | $18,207.47 | 2019-2025 | Cirrus Hd-Oct, Visumax, Iolmaster 700 |
| Bausch & Lomb Americas INC. | $12,241.73 | 2022-2025 | Victus, Stellaris, Stellaris Elite |
| Coherus Oncology, INC. | $6,305.38 | 2023 | |
| Beaver-Visitec International, INC. | $5,600.00 | 2025 | |
| Genentech USA, INC. | $3,256.91 | 2019-2025 | Susvimo, Vabysmo |
| Regeneron Pharmaceuticals, INC. | $2,144.87 | 2024-2025 | Eylea Hd, Eylea |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $600.00 | 2023 | |
| Kala Pharmaceuticals, INC. | $178.22 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $77.27 | 2025 | Yutiq, Purified Cortrophin Gel |
| Neurotech Pharmaceuticals, INC. | $69.66 | 2025 | |
| Harrow Eye, LLC | $38.49 | 2025 | Triesence |
| Mallinckrodt Hospital Products INC. | $34.81 | 2020 | |
| Astellas Pharma US INC | $33.90 | 2025 | Izervay |
| Mallinckrodt Enterprises LLC | $31.69 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaurav Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.